Oncology Short Term Debt from 2010 to 2024

TOIIW Stock  USD 0.01  0  10.71%   
Oncology Institute Short Term Debt yearly trend continues to be fairly stable with very little volatility. Short Term Debt will likely drop to about 4.8 M in 2024. During the period from 2010 to 2024, Oncology Institute Short Term Debt regression line of quarterly data had mean square error of 2 T and geometric mean of  4,308,199. View All Fundamentals
 
Short Term Debt  
First Reported
2010-12-31
Previous Quarter
6.4 M
Current Value
4.8 M
Quarterly Volatility
1.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Oncology Institute financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncology Institute's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.8 M, Interest Expense of 7.1 M or Selling General Administrative of 67.6 M, as well as many indicators such as Price To Sales Ratio of 0.44, Dividend Yield of 0.0235 or PTB Ratio of 2.51. Oncology financial statements analysis is a perfect complement when working with Oncology Institute Valuation or Volatility modules.
  
Check out the analysis of Oncology Institute Correlation against competitors.
For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.

Latest Oncology Institute's Short Term Debt Growth Pattern

Below is the plot of the Short Term Debt of The Oncology Institute over the last few years. It is Oncology Institute's Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oncology Institute's overall financial position and show how it may be relating to other accounts over time.
Short Term Debt10 Years Trend
Pretty Stable
   Short Term Debt   
       Timeline  

Oncology Short Term Debt Regression Statistics

Arithmetic Mean5,058,687
Geometric Mean4,308,199
Coefficient Of Variation27.35
Mean Deviation686,143
Median5,368,000
Standard Deviation1,383,373
Sample Variance1.9T
Range6.2M
R-Value(0.21)
Mean Square Error2T
R-Squared0.04
Significance0.45
Slope(64,921)
Total Sum of Squares26.8T

Oncology Short Term Debt History

20244.8 M
20236.4 M
20225.5 M
2021183 K

About Oncology Institute Financial Statements

Oncology Institute investors use historical fundamental indicators, such as Oncology Institute's Short Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Oncology Institute. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short Term Debt6.4 M4.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Oncology Stock Analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.